Updated 04:19 GMT, 17 Nov 2026 SPX 7,416.59 -1.92% NDX 27,197.15 -2.67% VIX 22.91 +18.70% GOLD 3,872.70 -0.35% CL 84.95 -4.08% BTC 64,888.19 -0.64%
NAS100 27,197 −2.67% S&P 7,417 −1.92% GOLD $3,873 −0.35% BTC $64,888 −0.64% VIX 22.91 +18.70% latest tape · as of 04:19 UTC
The Screen · Financials · Asset Management

Bridgepoint Group plc

BPT.L · LSE · GBp · Market cap $271.4B · 542 employees

Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, lower mid-market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct len…

FAIL · Does not pass the screen
407.00 GBp

Price as of 13 Nov 2026Daily close, not a live quoteLast reviewed 4 days ago

Screened 2026-11-13 · the tape above runs as of 04:19 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price407.00 GBp at the 13 Nov 2026 close
  • Our value readOvervalued vs our fair value, as of 13 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • Last reviewed13 Nov 2026 (4 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

FAIR-VALUE RANGE

Our fair-value range: 203.50 GBp to 218.10 GBp, base estimate 203.50 GBp (screen dated 2026-11-13).

Current read
Markup ?
Overvalued · screened 2026-11-13
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price407.00 GBp
Fair value203.50
Ethical score30.0/100
Value readOvervaluedas of 13 Nov 2026
Our investment reviews on this name
2026-10-26Read Markup310.00+31.3% to today ✓Markdown gives way to Markup first Markup read since August
2026-10-02Read Markdown310.00+31.3% to today Markup gives way to Markdown after a 27% rise in 6 weeks
2026-08-23Read Markup244.40+66.5% to today ✓Accumulation gives way to Markup
2026-07-02Read Accumulation244.40+66.5% to today ✓First review on file: Accumulation

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Bridgepoint Group plc holds its Markup at $407.00. Elevated stress, defensive posture warranted, held for 19 days.

As held on the ledger · 2026-11-13
PhaseMarkup
Quantitative stateElevated stress, defensive posture warranted, held for 19 days
Price at the screen$407.00
Valuation6,200.00 trailing · 1,081.01 forward price to earnings
Values screenFAIL · score 30.0
Beta1.37
The Workings

Five Screens, Shown in Full

Does not pass. Prohibited keyword in sector/industry: financial services

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Prohibited keyword in sector/industry: financial services Fail
Debt load Excluded Below 33% Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash Excluded Below 33% Interest-bearing cash and securities are of assets, above the one-third limit. Fail
Receivables Excluded Below 49% Money owed to the company is of assets, above the 49% limit. Fail
Revenue purity Excluded Below 5% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Bridgepoint does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.

Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when BPT.L's ethical verdict changes

Today BPT.L does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Overvalued vs our fair value, as of 13 Nov 2026: it trades above our 203.50 GBp fair value estimate, 26.40% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

203.50Conservative203.50Base case218.10Growth case 407.00Price

Fair value range in GBp, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. The price runs 100.0% above the base estimate.

The Street's Range
300.00Street low 375.00Street average 440.00Street high 407.00Price

Third-party analyst targets: 8 covering, consensus Buy. The average target sits −8% from the screen price.

Reading the gap · Both our model and the Street see limited upside at this price.

Projections

Where our models see it going: fair-value estimate 203.50 GBp, with a range of 203.50 GBp to 218.10 GBp, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Why it gives us pause

At 1,081.0x forward earnings, the price already runs ahead of the business. It trades 100% above our 203.50 GBp fair value, so you would be buying at a premium, not a discount.

The fundamentals · plain-English read
Forward P/E1,081.0xexpensive even after accounting for its growth
Trailing P/E6,200.0xexpensive: the price assumes strong growth ahead
EPS, trailing0.05
EPS, forward0.29
Revenue growth+26.4%strong top-line growth
Profit margin6.6%thin but positive margins
Return on equity4.8%a modest return on shareholder capital
FCF yield-26.78%
Dividend yield3.52%
Debt to equity0.53moderate, manageable leverage
Current ratio7.22comfortably covers its short-term bills
Beta1.37moves a little more than the market
52-week range212.00 - 366.68
Market cap$271.4B
Employees542

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it already moves more than the market on an average day; its business and earnings are exposed to United Kingdom and to currency swings.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

BPT.L trades on LSE (the company is based in United Kingdom). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-06 Markup $414.00 +33.5% Entry 9

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 33.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (8 analysts) rates it buy, with a mean price target of $374.

2026-10-26 Markup · changed $310.00 +0.0% Entry 8

The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (8 analysts) rates it buy, with a mean price target of $374.

2026-10-14 Markdown $310.00 +0.0% Entry 7

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (8 analysts) rates it buy, with a mean price target of $374.

2026-10-02 Markdown · changed $310.00 +26.8% Entry 6

The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 26.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (8 analysts) rates it buy, with a mean price target of $374. Since the last review it its composite score eased.

2026-08-23 Markup · changed $244.40 +0.0% Entry 5

The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (8 analysts) rates it buy, with a mean price target of $374.

2026-07-23 Accumulation $244.40 +0.0% Entry 4

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (8 analysts) rates it buy, with a mean price target of $374.

2026-07-18 Accumulation $244.40 +0.0% Entry 3

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (8 analysts) rates it buy, with a mean price target of $374.

2026-07-03 Accumulation $244.40 +0.0% Entry 2

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.

2026-07-02 Accumulation $244.40 Entry 1

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $265.00 -7.8% · $922 -7.8%
2 months $240.36 +1.7% $4.70 $1,036 +3.6%
3 months $226.96 +7.7% $4.70 $1,098 +9.8%
6 months $277.55 -11.9% $4.70 $898 -10.2%
1 year $300.11 -18.6% $9.40 $846 -15.4%
2 years $210.87 +15.9% $18.60 $1,247 +24.7%
3 years $223.77 +9.2% $27.40 $1,215 +21.5%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever BPT.L does next, these words stay.

Bridgepoint Group plc · BPT.L · Markup · $407.00
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.